Demethylcryptojaponol

Demethylcryptojaponol

SCHEMBL16006713

CC(C)c1cc2c(c(O)c1O)[C@@]1(C)CCCC(C)(C)C1CC2=O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FDPS P14324 14/20 0.67
▸ GGPS1 O95749 5/20 0.67
▸ PTGES O14684 2/20 0.50
▸ PNLIP P16233 2/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ BCL9 O00512 3/20 0.48
▸ CTNNB1 P35222 3/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ ALOX12 P18054 1/20 0.48
▸ GSTO1 P78417 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ USP2 O75604 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Demethylcryptojaponol SCHEMBL13532270 1.00 FDPS (0.67) FDPSGGPS1PTGESPNLIPMEN1
Demethylcryptojaponol SCHEMBL28596866 1.00 FDPS (0.67) FDPSGGPS1PTGESPNLIPMEN1
Cryptojaponol SCHEMBL18290238 0.89 FDPS (0.60) FDPSGGPS1PTGESPNLIPMEN1
Cryptojaponol SCHEMBL30600453 0.89 FDPS (0.60) FDPSGGPS1PTGESPNLIPMEN1
Cryptojaponol SCHEMBL13532267 0.89 FDPS (0.60) FDPSGGPS1PTGESPNLIPMEN1
SCHEMBL13533287 0.85 FDPS (0.54) FDPSGGPS1PTGESPNLIPMEN1
Sugiol SCHEMBL28605319 0.81 SOD1 (0.58) FDPSGGPS1PTGESPNLIPMEN1
Sugiol SCHEMBL1086916 0.81 SOD1 (0.58) FDPSGGPS1PTGESPNLIPMEN1
Sugiol SCHEMBL17407685 0.81 SOD1 (0.58) FDPSGGPS1PTGESPNLIPMEN1
6-Alpha-Hydroxydemethyl-Cryptojaponol SCHEMBL18290237 0.81 SOD1 (0.54) FDPSGGPS1PTGESPNLIPMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10464963-B2 Compounds from invasive Salvinias and methods of using the same STEPHEN F. AUSTIN STATE UNIVERSITY (US) 2019-11-05 — — US disclosed
US-20180057524-A1 COMPOUNDS FROM INVASIVE SALVINIAS AND METHODS OF USING THE SAME STEPHEN F. AUSTIN STATE UNIVERSITY 2018-03-01 — — US disclosed
US-20180057524-A1 COMPOUNDS FROM INVASIVE SALVINIAS AND METHODS OF USING THE SAME STEPHEN F. AUSTIN STATE UNIVERSITY 2018-03-01 — — US disclosed
US-9809615-B2 Anti-cancer compounds from invasive salvinias and methods of treating cancer STEPHEN F. AUSTIN STATE UNIVERSITY (US) 2017-11-07 — — US disclosed
US-9809615-B2 Anti-cancer compounds from invasive salvinias and methods of treating cancer STEPHEN F. AUSTIN STATE UNIVERSITY (US) 2017-11-07 — — US disclosed
US-20160002279-A1 COMPOUNDS FROM INVASIVE SALVINIAS AND METHODS OF USING THE SAME STEPHEN F. AUSTIN STATE UNIVERSITY 2016-01-07 — — US disclosed
US-20160002279-A1 COMPOUNDS FROM INVASIVE SALVINIAS AND METHODS OF USING THE SAME STEPHEN F. AUSTIN STATE UNIVERSITY 2016-01-07 — — US disclosed
WO-2014133811-A2 COMPOUNDS FROM INVASIVE SALVINIAS AND METHODS OF USING THE SAME STEPHEN F. AUSTIN UNIVERSITY (US) 2014-09-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10464963-B2 Compounds from invasive Salvinias and methods of using the same MMP8, GUSB, MMP9 FDPS 995/4885GGPS1 749/4885PTGES 250/4885
US-20180057524-A1 COMPOUNDS FROM INVASIVE SALVINIAS AND METHODS OF USING THE SAME MMP8, GUSB, MMP9 FDPS 995/4885GGPS1 749/4885PTGES 250/4885
US-20160002279-A1 COMPOUNDS FROM INVASIVE SALVINIAS AND METHODS OF USING THE SAME MMP8, GUSB, MMP9 FDPS 995/4885GGPS1 749/4885PTGES 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback